Skip to main content
Press Release

Haverhill Man Pleads Guilty to Prescription Fraud Charges

For Immediate Release
U.S. Attorney's Office, District of New Hampshire

            CONCORD - Theodoros Bahtsevanos, 32, currently of Haverhill, Massachusetts, pleaded guilty in federal court to prescription fraud and false identity document charges, United States Attorney Scott W. Murray announced.

            According to court documents and statements made in court, Bahtsevanos passed false prescriptions for Adderall, a controlled substance, at pharmacies in Nashua and Derry, New Hampshire on two occasions in May of 2018.  The prescriptions contained falsified signatures but actual DEA registration numbers for physicians, and were issued to aliases Bahtsevanos was using at the time.  When Bahtsevanos was arrested, he was found in possession of nine fake driver’s licenses purporting to be from states all over the country.  Each fake license bore his photograph and used a different alias.  Bahtsevanos also had a ledger book through which he tracked various DEA registration numbers, physician’s names, and fake recipients that he used to fill prescriptions for Adderall throughout New Hampshire.  Investigators found that he filled more than 90 fake prescriptions as part of the scheme.

            Bahtsevanos is scheduled to be sentenced on September 16, 2019.  

            “Protecting the integrity of our health care system is a high priority of the U.S. Attorney’s Office,” said U.S. Attorney Murray.  “Those who obtain prescription drugs by fraudulent means divert drugs from their intended uses and may contribute to the unlawful drug trade.  We will continue to work with our law enforcement partners to identify and prosecute those who participate in unlawful schemes to obtain prescription drugs.”

            This matter was investigated by the Drug Enforcement Administration’s Office of Diversion Control, the New Hampshire State Police, Derry Police Department, Nashua Police Department, and Massachusetts State Police.  The case is being prosecuted by Assistant U.S. Attorney Charles L. Rombeau.        




Updated June 12, 2019

Prescription Drugs
Press Release Number: 19-098